Latest Phase 3 Results Demonstrate Safety and Efficacy Profile of INVOKANA® (canagliflozin) as Add-On Therapy in the Treatment of Type 2 Diabetes in Adults
- EMEA Innovative Medicine
- Phase 3 Results Show Safety and Efficacy of INVOKANA® (canagliflozin)
Phase 3 Results Show Safety and Efficacy of INVOKANA® (canagliflozin)
- X (Twitter)
Copy link